Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

China · Delayed Price · Currency is CNY

4.980

+0.210 (4.40%)

Jul 27, 2026, 3:00 PM CST

SHA:600538 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	332.27	328.24	340.47	369.15	459.68	424.72
Revenue Growth	0.23%	-3.59%	-7.77%	-19.69%	8.23%	58.65%
Gross Profit	70.3	66.92	85.78	89.7	126.71	108.12
Operating Income	-28.09	-29.36	-15.21	-21.35	24.53	9.42
Net Income	-98.32	-87.62	-93.85	-82.31	34.84	10.49
Earnings Per Share	-0.16	-0.17	-0.18	-0.16	0.07	0.02
EPS Growth	-	-	-	-	250.00%	185.71%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Intersegment Elimination	-0.7
Pharmaceutical Distribution [Industry]	190.47
DNA Testing Equipment, Consumables and Testing Services	106.85
Others	1.77
Pharmaceutical Manufacturing	27.15
Total	325.54

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	122.88	150.77	144.84	155.26	170.86	190.4
Total Debt	55.19	55.9	41.6	15.81	14.52	6.46
Net Cash (Debt)	67.68	94.87	103.24	139.45	156.34	183.95
Net Cash Growth	-23.47%	-8.11%	-25.97%	-10.80%	-15.01%	-19.14%
Net Cash Per Share	0.11	0.18	0.20	0.27	0.31	0.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-18.55	-13.4	1.95	-17.97	-15.74	-6.34
Capital Expenditures	-5.6	-6.46	-10.07	-10.03	-7.77	-23.29
Free Cash Flow	-24.15	-19.86	-8.12	-28	-23.51	-29.63
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	21.16%	20.39%	25.20%	24.30%	27.56%	25.46%
Operating Margin	-8.45%	-8.95%	-4.47%	-5.79%	5.34%	2.22%
Pretax Margin	-28.70%	-25.82%	-27.02%	-21.01%	9.16%	3.72%
Profit Margin	-29.59%	-26.69%	-27.57%	-22.30%	7.58%	2.47%
FCF Margin	-7.27%	-6.05%	-2.38%	-7.58%	-5.11%	-6.98%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	68.00	301.93
PS Ratio	7.86	9.77	7.95	6.59	5.15	7.46